Reviva Pharmaceuticals Holdings (RVPH) Other Operating Expenses (2018 - 2020)
Reviva Pharmaceuticals Holdings (RVPH) posted Other Operating Expenses of $352007.0 for Q4 2020, down 33.07% sequentially from $525924.0 in Q3 2020, and up 112.02% YoY from $166022.0 in Q4 2019.
Reviva Pharmaceuticals Holdings (RVPH) Other Operating Expenses (2018 - 2020) Analysis & Trends
Reviva Pharmaceuticals Holdings has reported Other Operating Expenses for 3 years, with the latest figure at $352007.0 in Q4 2020.
- Quarterly Other Operating Expenses rose 112.02% year-over-year to $352007.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was $352007.0 (changed N/A YoY) and the FY2020 annual result came in at $724740.0, up 374.34% from the prior year.
- Other Operating Expenses declined to $352007.0 in Q4 2020 per RVPH's latest filing, from $525924.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $525924.0 in Q3 2020 and troughed at $2328.0 in Q3 2018.
- A 3-year average of $174328.2 and a median of $94110.0 in 2019 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 3942.53% in 2019, down 109.77% in 2019.
- Over 3 years, Other Operating Expenses stood at $79146.0 in 2018, then jumped by 109.77% to $166022.0 in 2019, then jumped by 112.02% to $352007.0 in 2020.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $352007.0, $525924.0, and $264941.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Reviva Pharmaceuticals Holdings | 6.74 Mn | 6.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2020 | 352,007.00 |
| Aug 31, 2020 | 525,924.00 |
| May 31, 2020 | 264,941.00 |
| Nov 30, 2019 | 166,022.00 |
| Aug 31, 2019 | 94,110.00 |
| May 31, 2019 | 71,135.00 |
| Nov 30, 2018 | 79,146.00 |
| Aug 31, 2018 | 2,328.00 |
| May 31, 2018 | 13,341.00 |